期刊文献+

ACE2在高血压大鼠左心室重构中的作用及缬沙坦干预的作用 被引量:1

The role of ACE2 in ventricular remodeling and effect of valsartan treatment on the spontaneously hypertensive rats
下载PDF
导出
摘要 目的观察血管紧张素转换酶2(ACE2)在自发性高血压大鼠(SHR)左心室中的表达以及缬沙坦干预后对ACE2表达水平的影响。方法 24只12周龄雄性SHR随机分为SHR组、缬沙坦组,12只同龄雄性血压正常的Wistar大鼠作为正常对照组。10周后处死,测定心脏重量指数(HWI)、左心室重量指数(LVWI);酶联免疫法测定血浆中AngⅡ的浓度;碱水解法测定心肌中羟脯氨酸的含量;反转录-聚合酶链反应检测心肌中ACE2的表达。结果与正常对照组比较,SHR组LVWI、血浆中AngⅡ的浓度以及心肌羟脯氨酸的含量均增高(P<0.05),心肌组织中ACE2的表达显著降低(P<0.05);与SHR组比较,缬沙坦组LVWI、血浆中AngⅡ的浓度以及心肌羟脯氨酸的含量均降低(P<0.05),心肌组织中ACE2表达显著增高(P<0.05)。结论缬沙坦可逆转高血压左心室重构,机制可能与增加心肌中ACE2的表达有关。 Objective To investigate the expression of angiotensin converting enzyme 2(ACE2) in the SHR,and the effect of valsartan on the expression of ACE2 mRNA.Methods Twenty-four Twelve-week-old male SHR were randomly divided to SHR group and valsartan group;Twelve-week-old male Wistar rats were served as control group.After 10 weeks,determine the heart weight index and the 1eft ventricular weight index;determine the concentration of AngⅡ in plasma by ELISA;determine the hydroxyproline content in myocardium by buck solution;The expression of ACE2 mRNA in myocardium was measured by RT-PCR.Results Compared with the control group,the LVWI,the hydroxyproline content and the concentration of AngⅡ were significantly increased in the SHR group,but the ACE2 expression was markedly decreased;compared with SHR group,the above indexes were decreased except for ACE2 was increased in valsartan group.Conclusions Valsartan can reverse left ventricular remoding in hypertension.The possible mechanism is that valsartan can incerease the expression of ACE2.
出处 《基础医学与临床》 CSCD 北大核心 2012年第6期678-681,共4页 Basic and Clinical Medicine
基金 山东省医药科技发展计划(2009HW008)
关键词 血管紧张素转换酶2 左心室重构 缬沙坦 自发性高血压大鼠 angiotensin converting enzyme 2 vascular remoding valsartan spontaneously hypertensive rats
  • 相关文献

参考文献1

二级参考文献11

共引文献5

同被引文献13

  • 1Chamberland C,Martinez HB ,Haufe V ,et al. Modulation of canine cardiac sodium current by Apelin[J]. J Mol Cell Cardiol,2010,48(4) : 694-701.
  • 2Japp AG,Cruden NL,Barnes G,et al. Acute cardiovascular effects of Apelin in humans: potential role in patients with chronic heart failure[J]. Circulation, 2010,121 (16) : 1818-1827.
  • 3McMurray JV,Adamopoulos S,Anker SD,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J]. European Heart J,2012,33(14) : 1787-1847.
  • 4Mattu HS, Randeva HS. Role of adipokines in cardiovascular disease[J]. J Endocrinol,2013,216(1) :T17-T36.
  • 5Rastaldo R,Cappello S,Folino A,et al. Apelin-13 limits infarct size and improves cardiac post-ischemic mechanical recovery only if given after ischemia [J]. Am J Physiol Heart Circ Physiol,2011,300(6): H2308-H2315.
  • 6Japp AG,Craden NL,Flapan AD,et al. The in-vivo cardiovascular effeets of APJ agonism in healthy subjeets and patients with chronic heart failure[J]. Heart, 2009,95 : B.
  • 7Zhu S,Sun F,Li W,et al. Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes[J]. Mol Cell Biochem, 2011,353 (1-2) : 305-313.
  • 8Zhang Q,Yao FR,Mohan K,et al. Apelin gene transfer into the rostral ventrolateral medulla induces chronic blood pressure elevation in normotensive rats[J]. Circ Res, 2009,104 : 1421-1428.
  • 9Koguchi W, Kobayashi N ,Takeshima H ,et al. Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure[J]. Circ J ,2012,76( 1 ) : 137-144.
  • 10Kosmala MP, Kotwica T, Mysiak A, et al. Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction[J]. J Hypertens, 2011,29 (5) : 971-979.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部